Once‐Weekly Insulin Efsitora Alfa Versus Once Daily Insulin in Patients With Type 2 Diabetes: A Systematic Review and Meta‐Analysis

ABSTRACT Background Once‐daily basal insulin is widely used in the management of type 2 diabetes, but poor adherence to daily injections often impairs glycaemic control. Once‐weekly efsitora alfa may overcome these limitations, but pooled data assessing its comparative efficacy and safety remain lim...

Descripción completa

Detalles Bibliográficos

Autores principales:	Harris Mehmood, Moaz Alowami, Thel Su Hlaing, Khant Nyi Zaya, Yousrah Uraiby, Ahmed Muaaz Alam, Abubakr Adala, Osama Ikram, Syed Faisal Ali, Muzammil Farhan, Eeshal Zulfiqar, Mushood Ahmed, Raheel Ahmed, Ammara Naeem
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2025-11-01
Colección:	Endocrinology, Diabetes & Metabolism
Materias:	basal insulin Fc daily basal insulin diabetes efsitora type‐2 diabetes weekly insulin
Acceso en línea:	https://doi.org/10.1002/edm2.70126
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!